American Healthcare REIT - AHR Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $25.13
  • Forecasted Upside: -11.38%
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$28.35
▲ +0.18 (0.64%)

This chart shows the closing price for AHR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New American Healthcare REIT Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AHR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AHR

Analyst Price Target is $25.13
▼ -11.38% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for American Healthcare REIT in the last 3 months. The average price target is $25.13, with a high forecast of $31.00 and a low forecast of $14.00. The average price target represents a -11.38% upside from the last price of $28.35.

This chart shows the closing price for AHR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 8 contributing investment analysts is to moderate buy stock in American Healthcare REIT.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/23/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/22/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/20/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/18/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/17/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/17/2024

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/18/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$28.00 ➝ $30.00
11/15/2024Truist FinancialBoost TargetBuy ➝ Buy$27.00 ➝ $29.00
10/13/2024Colliers SecuritiesUpgradeHold ➝ Moderate Buy
9/24/2024Bank of AmericaBoost TargetBuy ➝ Buy$27.00 ➝ $31.00
9/20/2024Truist FinancialBoost TargetBuy ➝ Buy$22.00 ➝ $27.00
9/20/2024JMP SecuritiesBoost TargetMarket Outperform ➝ Market Outperform$18.00 ➝ $30.00
9/16/2024KeyCorpBoost TargetOverweight ➝ Overweight$16.00 ➝ $27.00
9/3/2024Truist FinancialBoost TargetBuy ➝ Buy$17.00 ➝ $22.00
8/22/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$17.00 ➝ $22.00
8/20/2024Bank of AmericaBoost TargetBuy ➝ Buy$19.00 ➝ $27.00
8/8/2024Bank of AmericaBoost TargetBuy ➝ Buy$16.00 ➝ $19.00
8/7/2024JMP SecuritiesBoost TargetMarket Outperform ➝ Market Outperform$16.00 ➝ $18.00
7/1/2024Truist FinancialReiterated RatingBuy ➝ Buy$16.00 ➝ $17.00
5/16/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$16.00
4/3/2024Truist FinancialLower TargetBuy ➝ Buy$17.00 ➝ $16.00
3/25/2024Truist FinancialReiterated RatingBuy ➝ Buy$17.00
3/25/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$16.00
3/14/2024BarclaysInitiated CoverageOverweight$18.00
3/4/2024Bank of AmericaInitiated CoverageBuy$15.00
3/4/2024KeyCorpInitiated CoverageOverweight$16.00
3/4/2024JMP SecuritiesInitiated CoverageMkt Outperform$16.00
3/4/2024CitigroupInitiated CoverageNeutral$14.00
3/4/2024Royal Bank of CanadaInitiated CoverageOutperform$15.00
3/4/2024Morgan StanleyInitiated CoverageOverweight$17.00
3/4/2024Truist FinancialInitiated CoverageBuy$17.00
(Data available from 12/18/2019 forward)

News Sentiment Rating

1.29 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/22/2024
  • 3 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/21/2024
  • 7 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/21/2024
  • 8 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/20/2024
  • 9 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/19/2024
  • 18 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/19/2024
  • 29 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
11/18/2024
  • 37 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/18/2024

Current Sentiment

  • 37 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
American Healthcare REIT logo
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value. The company benefits from a fully integrated management platform comprised of more than one hundred experienced and skilled professionals, many of whom have worked together since 2006 and have successfully invested in and managed healthcare real estate through multiple market cycles. The management team has a proven track record, deep industry relationships and unparalleled insight into each of the company's assets having built and nurtured the company's international portfolio since its original property acquisition in 2014. The strength of the management team, coupled with the quality of the assets, has American Healthcare REIT poised to capitalize on compelling growth driven by powerful demographic trends. With its 19 million-square-foot, 312-building portfolio of medical office buildings, senior housing communities, skilled nursing facilities and integrated senior health campuses diversified across 36 states and the United Kingdom, the tri-party transaction was a critical step in ideally positioning American Healthcare REIT for a future public listing or IPO on a national stock exchange at the most opportune time. By listing the company's shares on a national exchange, we believe the company will gain greater access to attractive capital that will fuel future growth, broaden our investor base and also provide liquidity to our fellow stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.
Read More

Today's Range

Now: $28.35
Low: $27.85
High: $28.66

50 Day Range

MA: $26.89
Low: $24.20
High: $29.83

52 Week Range

Now: $28.35
Low: $12.63
High: $29.99

Volume

1,366,260 shs

Average Volume

1,529,409 shs

Market Capitalization

$4.34 billion

P/E Ratio

N/A

Dividend Yield

3.53%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of American Healthcare REIT?

The following Wall Street sell-side analysts have issued research reports on American Healthcare REIT in the last twelve months: Bank of America Co., Barclays PLC, Citigroup Inc., Colliers Securities, JMP Securities, KeyCorp, Morgan Stanley, Royal Bank of Canada, and Truist Financial Co..
View the latest analyst ratings for AHR.

What is the current price target for American Healthcare REIT?

0 Wall Street analysts have set twelve-month price targets for American Healthcare REIT in the last year. Their average twelve-month price target is $25.13, suggesting a possible downside of 11.4%. Bank of America Co. has the highest price target set, predicting AHR will reach $31.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $14.00 for American Healthcare REIT in the next year.
View the latest price targets for AHR.

What is the current consensus analyst rating for American Healthcare REIT?

American Healthcare REIT currently has 1 hold rating and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for AHR.

What other companies compete with American Healthcare REIT?

How do I contact American Healthcare REIT's investor relations team?

American Healthcare REIT's physical mailing address is 18191 Von Karman Avenue, Suite 300, Irvine, CA 92612-7106, United States. The company's listed phone number is 949-270-9200 and its investor relations email address is [email protected]. The official website for American Healthcare REIT is www.americanhealthcarereit.com. Learn More about contacing American Healthcare REIT investor relations.